This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gibot, S. Articles by Lévy, B. Search for Related Content PubMed PubMed Citation Articles by Gibot, S. Articles by Lévy, B.

 Previous Article  |  Next Article 

Infection and Immunity, May 2006, p. 2823-2830, Vol. 74, No. 5
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.5.2823-2830.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Modulation of the Triggering Receptor Expressed on the Myeloid Cell Type 1 Pathway in Murine Septic Shock

Sébastien Gibot,^1,* Cecilia Buonsanti,^2, Frédéric Massin,³ Michele Romano,² Marie-Nathalie Kolopp-Sarda,³ Fabio Benigni,² Gilbert C. Faure,³ Marie-Christine Béné,³ Paola Panina-Bordignon,² Nadia Passini,² and Bruno Lévy¹

Service de Réanimation Médicale, Hôpital Central and Laboratoire de Physiologie Expérimentale (Groupe Choc), Nancy, France,¹ Bioxell Spa, Milano, Italy,² Laboratoire d'Immunologie, Nancy, France³

Received 7 November 2005/ Returned for modification 18 January 2006/ Accepted 15 February 2006

The triggering receptor expressed on myeloid cell type 1 (TREM-1) is a cell surface molecule that has been identified on both human and murine polymorphonuclear neutrophils and mature monocytes. The activation of TREM-1 in the presence of microbial components amplifies the inflammatory response and may be responsible for the hyperresponsiveness observed during the initial stage of sepsis. To investigate the effect of the modulation of the TREM-1 pathway during experimental murine sepsis, we used analogue synthetic peptides derived from the extracellular moiety of TREM-1. The TREM-1 ligand was expressed on both peritoneal and peripheral neutrophils during experimental peritonitis in mice. The TREM-1 peptides inhibited the recognition by TREM-1 of its ligand and protected endotoxinic mice from death. In septic rats, the TREM-1 peptides improved the hemodynamic status, attenuated the development of lactic acidosis, modulated the production of such proinflammatory cytokines as tumor necrosis factor alpha and interleukin-1ß, and improved survival. The protective effect of these peptides on arterial pressure could partly be explained by a decreased production of nitric oxide. These data suggest that in vivo modulation of TREM-1 might be a suitable therapeutic tool for the treatment of sepsis.

Editor: F. C. Fang

These authors contributed equally to this work.

This article has been cited by other articles:

• Dower, K., Ellis, D. K., Saraf, K., Jelinsky, S. A., Lin, L.-L. (2008). Innate Immune Responses to TREM-1 Activation: Overlap, Divergence, and Positive and Negative Cross-Talk with Bacterial Lipopolysaccharide. J. Immunol. 180: 3520-3534 [Abstract] [Full Text]  
• Ornatowska, M., Azim, A. C., Wang, X., Christman, J. W., Xiao, L., Joo, M., Sadikot, R. T. (2007). Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L1377-L1384 [Abstract] [Full Text]  
• Gomez-Pina, V., Soares-Schanoski, A., Rodriguez-Rojas, A., del Fresno, C., Garcia, F., Vallejo-Cremades, M. T., Fernandez-Ruiz, I., Arnalich, F., Fuentes-Prior, P., Lopez-Collazo, E. (2007). Metalloproteinases Shed TREM-1 Ectodomain from Lipopolysaccharide-Stimulated Human Monocytes. J. Immunol. 179: 4065-4073 [Abstract] [Full Text]  
• Remick, D. G. (2007). Pathophysiology of Sepsis. Am. J. Pathol. 170: 1435-1444 [Abstract] [Full Text]